Chromatin Announces Anthony J. Cavalieri, Former Pioneer Hi-Bred VP, Joins Board of Directors.Business Editors/Health/Medical Writers BIOWIRE2K CHICAGO--(BUSINESS WIRE)--March 17, 2004 Former VP of Trait and Technology Development Brings Top Level Agricultural Plant Genetics and Regulatory Experience Chromatin chromatin: see chromosome. , Inc. announced today that Anthony J. Cavalieri, Ph.D., has joined the company's board of directors. Cavalieri recently retired as vice president in charge of trait and technology development at Pioneer Hi-Bred Pioneer Hi-Bred is one of the largest U.S. companies which produces hybrid seeds for agriculture. History In 1926, farm journal editor and future U.S. Vice President Henry A. Wallace, along with a group of Des Moines, Iowa businessmen, started the "Hi-Bred Corn Company". , a DuPont company. "Tony's understanding of the agriculture biotechnology business and what the key drivers are for profitability will be extremely valuable to the development of Chromatin," said Mich Hein, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Chromatin. "His contacts in the industry and the respect that he commands are unequaled. Tony is known for developing and managing the premier commercial trait discovery and introduction program in the world." "Chromatin's mini-chromosomes represent one of the most significant developments in agricultural genetics that we have seen in a generation," said Cavalieri. "I am extremely pleased to be working with this exciting company and I think we have the potential to change the nature and scope of agricultural crop development." Cavalieri spent more than 20 years at Pioneer Hi-Bred International Inc., where he held a number of research leadership roles and had responsibility for many of the sciences contributing to crop improvement, regulatory affairs Regulatory Affairs (RA), also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs professionals usually have responsibility for the following general areas: DuPont acquired Pioneer Hi-Bred International Inc., at the time the world's largest commercial seed company, for $7.7 billion in 1999, signaling DuPont's commitment to agricultural genetics. As vice president of trait and technology development, Cavalieri led a large research group with responsibility for insect, disease and herbicide herbicide (hr`bəsīd'), chemical compound that kills plants or inhibits their normal growth. A herbicide in a particular formulation and application can be described as selective or nonselective. resistance, grain trait improvement, analytical biochemistry biochemistry, science concerned chiefly with the chemistry of biological processes; it attempts to utilize the tools and concepts of chemistry, particularly organic and physical chemistry, for elucidation of the living system. , transformation, gene expression, gene targeting Gene targeting is a genetic technique that uses homologous recombination to change an endogenous gene. The method can be used to delete a gene, remove exons, and introduce point mutations. Gene targeting can be permanent or conditional. and genomics research. Cavalieri played a significant role in initiating, developing and implementing Pioneer's strategy in genomics. This included the formation of numerous research collaborations with leading genomics companies. Following the acquisition of Pioneer by DuPont, he was heavily involved in the integration of the combined research groups. Cavalieri has served on numerous university biotechnology advisory groups. Cavalieri is a fellow of the Crop Science Society of America and a member of the American Society of Plant Biologists and Sigma XI Sigma Xi: The Scientific Research Society was founded in 1886 at Cornell University by a junior faculty member and a handful of graduate students. Members of the non-profit honor society elect others on the basis of their research achievements or potential. . He received his Ph.D. from the University of South Carolina
• • in biology. About Chromatin Chromatin, Inc. develops and markets novel proprietary technology that enables entire chromosomes to be designed and incorporated into plant cells. These engineered chromosomes make it possible for the first time to simultaneously introduce multiple genes into a plant cell while maintaining precise control of gene expression. Chromatin is employing these new genetic tools to design and market products that confer commercially valuable traits in plants, including improved nutritional and health characteristics, and can be used for industrial, agricultural and pharmaceutical product development. For more information, go to www.chromatininc.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion